Interdisciplinary Symposium on COVID-19 (Virtual edition)
24 June 2021, Virtual
Interdisciplinary Symposium on COVID-19 (Virtual edition)
Interdisciplinary Symposium on COVID-19 (Virtual edition)
Add to calendar
Bart Lambrecht
Xavier Saelens
The COVID-19 global pandemic has disrupted nearly all aspects of modern life, while long-term psychological, socio-economic, and health impacts remain unknown. Medical and academic personnel are deeply involved in the struggle against the virus, and need support to not become overwhelmed by available scientific information.
Therefore, four Belgian professional societies (Virology, Immunology, Microbiology and Clinical Microbiology and Infectious Diseases) have joined forces in the organization of a one-day, Interdisciplinary symposium on COVID-19. We are convinced that our program will provide a comprehensive summary of contemporary knowledge on COVID-19
We present four consecutive sessions, each hosted by one society and featuring both a keynote lecture and two complementary presentations. There will be room for young scientists to present their work in short, pre-recorded talks. The closing lecture will be given by Prof. Stanley Perlman, one of the most prominent academic voices on Sars-CoV-2.
The meeting is accredited for 4.5 hours of postgraduate training.
The registration will be free of charge but mandatory.
Confirmed speakers
Program
Symposium - Thursday, 24 June, 2021
08:50
09:00
Welcome word
09:00
10:30
Basic virology, host cell interactions and pathological manifestations
accreditering 21006064
09:00
09:25
Pandemic preparedness and the development of antiviral strategies against SARS-CoV2
Johan Neyts
KULeuven, BE
09:25
09:50
From Genome to Function - Phenotypic Characterisation of Pandemic SARS-CoV-2 Variants.
Volker Thiel
University of Bern, CH
09:50
10:15
Immunopathology of severe Covid-19
Bart Lambrecht
VIB-UGent Center for Inflammation Research, BE
10:15
10:30
Panel discussion
Bart Lambrecht
VIB-UGent Center for Inflammation Research, BE
Volker Thiel
University of Bern, CH
Johan Neyts
KULeuven, BE
10:30
10:45
Coffee break
10:45
12:15
Current therapies and non-pharmaceutical Interventions
accreditering 21006065
10:45
11:10
Fighting COVID-19 with a cross-neutralising antibody
Davide Corti
Vir Biotechnology, US
11:10
11:35
From SARS-CoV-2 to COVID-19 : pharmaceutical interventions against the virus and in support of the host
Nicolas Dauby
CHU Saint-Pierre, BE
11:35
12:00
Assessing the impact on the spread of COVID-19 of non-pharmaceutical interventions in Belgium
Niel Hens
UHasselt, BE
12:00
12:15
Panel discussion
12:15
12:30
Selected abstracts
12:15
12:18
Evaluation of a microbiome throat spray in COVID-19 outpatients: a randomized, double-blind, placebo-controlled pilot trial (MiCel study)
Ilke De Boeck
University of Antwerp, BE
12:18
12:21
Hyperactivated mononuclear phagocytes, type II interferon and cytotoxic T cells with restricted clonal repertoire underly SARS-CoV2 related multisystem inflammatory syndrome in children
Levi Hoste
Ghent University Hospital, BE
12:21
12:24
Anti-SARS-CoV-2 antibodies in new-onset type 1 diabetes in children during pandemic in Belgium
Anissa Messaaoui
Hôpital Universitaire des Enfants Reine Fabiola - Université Libre de Bruxelles, BE
12:24
12:27
A dynamic COVID-19 mucin mRNA signature associates with disease presentation and severity
Annemieke Smet
Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, BE
12:27
12:30
Identification of a new Sars-CoV-2 lineage with spike mutations 69/70del, L452R and S477N in Belgium
Merijn Vanhee
AZ Delta General Hospital, Department of Laboratory Medicine, BE
12:30
13:15
Lunch break & Poster session
13:15
14:50
Epidemiology and socio-economic impact
accreditering 21006067 (Ethics & Economy)
13:15
13:35
Molecular epidemiological approaches to track and understand the dispersal dynamic of SARS-CoV-2
Simon Dellicour
ULB, BE
13:35
13:55
From health threat risk assessment to surveillance: the evolving epidemiological landscape of COVID-19
Sophie Quolin
Sciensano, BE
13:55
14:15
The welfare cost of vaccines allocation strategies
Sandy Tubeuf
UCLouvain, BE
14:15
14:35
Health care capacity, economics and mental wellbeing in pandemic times.
Philippe Beutels
UAntwerpen, BE
14:35
14:50
Panel discussion
Simon Dellicour
ULB, BE
Sophie Quolin
Sciensano, BE
Sandy Tubeuf
UCLouvain, BE
Philippe Beutels
UAntwerpen, BE
14:50
15:05
Coffee break
15:05
16:40
Immune response and Vaccines
accreditering 21006068
15:05
15:25
Immune response, protection and safety of current vaccines
Isabel Leroux-Roels
UZ Gent, BE
15:25
15:45
Thrombotic risk associated with COVID-19 pathogenesis and unusual thrombosis associated with thrombocytopenia in the context of COVID-19 vaccination
Jonathan Douxfils
University of Namur, QUALIblood, the AFMPS/FAGG, BE
15:45
16:05
Role of pre-existing T cell memory in COVID-19
Petra Bacher
Kiel University (CAU), DE
16:05
16:25
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity
Agnes Lehuen
Institut Cochin, CNRS8104, INSERM1016, Université de Paris, FR
16:25
16:40
Panel discussion
Isabel Leroux-Roels
UZ Gent, BE
Jonathan Douxfils
University of Namur, QUALIblood, the AFMPS/FAGG, BE
Petra Bacher
Kiel University (CAU), DE
Agnes Lehuen
Institut Cochin, CNRS8104, INSERM1016, Université de Paris, FR
16:40
17:15
Closing lecture
Coronaviruses: lessons learned
Stanley Perlman
University of Iowa, US
17:15
17:30
Closing words
Organizing committee
Bart Lambrecht
VIB-UGent Center for Inflammation Research, BE
Oliver Denis
CHU UCL Namur, BE
Herman Favoreel
UGent, BE
Deborah De Geyter
UZ Brussels, BE
Bénédicte Delaere
CHU UCL Namur, BE
Marta Romano
Sciensano, BE
Peter Delputte
UAntwerpen, BE
Benoît Muylkens
Université de Namur, BE
Niels Hellings
UHasselt, BE
Xavier Saelens
VIB-UGent Center for Medical Biotechnology, BE
Françoise Van Bambeke
UCLouvain, BE
Pieter-Jan Ceyssens
Sciensano, BE
Abstracts
The full list of abstracts will be available on 17-06-2021 until 07-07-2021
This list will only be available for registered attendees of the event.
This list will only be available for registered attendees of the event.
Attendees
The full list of attendees will be available on 17-06-2021 until 07-07-2021
This list will only be available for registered attendees of the event.
This list will only be available for registered attendees of the event.
